There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations – Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the IVD industry as it applies to emerging markets and the BRIC countries in particular.
A good number of reports on the BRIC and emerging markets have been published. Most of these focus on quantitative data such as the number of labs and hospitals, product registration regulations, and import taxes and conditions. Too many of them perhaps present merely a growth scenario without presenting the challenges the nations face and the challenges companies face when entering these markets. This report provides much of this information with its objective overview of the market for in vitro diagnostics in selected countries. This report also explores the opportunities that specific developing countries offer to IVD companies.
Kalorama also attempts to add some realistic aspects of working in a foreign country that are more qualitative in nature. Thus the report explores some of the cultural aspects of how the market for clinical diagnostics may evolve in a selection of emerging markets including the BRIC countries.
The discussion of each of the BRIC markets begins with a short introduction to the country and follows with a SWOT analysis of the market for IVDs. The SWOT analysis provides positive and negative aspects of market conditions. The author has decided to include positive and negative aspects of certain factors in the same SWOT category. The factors are classed positive or negative according to the strength of current market conditions. This is done to make the analysis comprehensive and easier to read.
The report covers data trends and issues, including:
- Healthcare trends and metrics in each country
- Physician Office Testing (POL) in BRIC Countries
- Disease Trends (Diabetes, Cancer, Allergy, Emerging Viruses)
- Lab Systems in BRIC Countries
- SWOT Analysis for Each BRIC Nation, Including:
- Strengths – factors that make the country attractive for IVD companies
- Weaknesses that form barriers to entry and success such as health insurance coverage, regulatory affairs and distribution issues
- Country elements that provide testing Opportunities
- Threats – a look at the competition and incumbents
- Key Companies Operating in Each Country
- Research and High Technology in BRIC Countries
- Other Trends (Insurance, Medical Tourism,
Market and economic trends are discussed from the point of view of their present and potential impact and there is a focus on the mix of economics, healthcare and diagnostics that may evolve in these countries.
The information presented in this report is derived from publicly available information sources such as company, government, and medical organization reports. It is combined with expert analysis based on the author’s industry knowledge combined with literature searches and interviews with industry professionals and experts in in vitro diagnostics.
All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.
For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at http://kaloramakeypoint.blogspot.com/